Early Prediction of Developing Type 2 Diabetes by Plasma Acylcarnitines: A Population-Based Study

Abstract

A panel of acylcarnitines, mainly involving mitochondrial lipid dysregulation, significantly improved predictive ability for type 2 diabetes beyond conventional risk factors. These findings need to be replicated in other populations, and the underlying mechanisms should be elucidated.